Your browser doesn't support javascript.
loading
Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO.
Vischioni, B; Dhanireddy, B; Severo, C; Bonora, M; Ronchi, S; Vitolo, V; Fiore, M R; D'Ippolito, E; Petrucci, R; Barcellini, A; Ciurlia, E; Iannalfi, A; Hasegawa, A; Molinelli, S; Mirandola, A; Valvo, F; Orecchia, R.
Affiliation
  • Vischioni B; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy. Electronic address: barbara.vischioni@cnao.it.
  • Dhanireddy B; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Radiation Medicine, Albert B. Chandler Hospital, University of Kentucky, USA.
  • Severo C; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Section of Radiological Sciences, University of Messina, Messina, Italy.
  • Bonora M; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Ronchi S; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Vitolo V; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Fiore MR; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • D'Ippolito E; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Petrucci R; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Barcellini A; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Ciurlia E; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Radiation Oncology Department, Vito Fazzi Hospital, Lecce, Italy.
  • Iannalfi A; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Hasegawa A; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Radiation Oncology Department, Osaka Heavy Ion Therapy Center, Osaka, Japan.
  • Molinelli S; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Radiation Oncology Department, Osaka Heavy Ion Therapy Center, Osaka, Japan.
  • Mirandola A; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Radiation Oncology Department, Osaka Heavy Ion Therapy Center, Osaka, Japan.
  • Valvo F; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Orecchia R; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Department of Radiotherapy, European Institute of Oncology, Milan, Italy.
Radiother Oncol ; 145: 172-177, 2020 04.
Article de En | MEDLINE | ID: mdl-32044529
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs des glandes salivaires / Carcinome adénoïde kystique / Radiothérapie par ions lourds / Réirradiation / Tumeurs de la tête et du cou Limites: Humans Langue: En Journal: Radiother Oncol Année: 2020 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs des glandes salivaires / Carcinome adénoïde kystique / Radiothérapie par ions lourds / Réirradiation / Tumeurs de la tête et du cou Limites: Humans Langue: En Journal: Radiother Oncol Année: 2020 Type de document: Article